Antibody evolution may predict COVID-19 outcomes

For COVID-19, the difference between surviving and not surviving severe disease may be due to the quality, not the quantity, of the patients’ antibody development and response, suggests a new study.

Harvard Gazette • harvard
Nov. 13, 2020 ~3 min

covid-19 health-medicine ragon-institute antibody-evolution igg-antibodies

Vaccines can protect against COVID-19 in animal models, study says

Harvard-affiliated Beth Israel Deaconess Medical Center has developed vaccines — currently being tested in animal models — that are designed to train the body’s immune system to recognize the virus swiftly upon exposure and respond quickly to disable it.

Harvard Gazette • harvard
May 20, 2020 ~8 min

covid-19 coronavirus harvard-medical-school health-medicine ragon-institute vaccine sars-cov-2 dan-h-barouch re-infection

Ragon Institute receives major gift to expand research into autoimmune diseases

Immunology research at the Ragon Institute of MGH, MIT, and Harvard has advanced an HIV vaccine into the clinic, and will diversify thanks to a major gift from Phillip T. and Susan M. Ragon.

Mary Todd Bergman • harvard
Sept. 19, 2019 ~9 min

 science-technology  public-health  basic-research  immunology  bruce-walker  phillip-t-terry-and-susan-m-ragon  ragon-institute  vaccines